Tscan Therapeutics Stock Last Dividend Paid

TCRX Stock  USD 2.10  0.08  3.96%   
Tscan Therapeutics fundamentals help investors to digest information that contributes to Tscan Therapeutics' financial success or failures. It also enables traders to predict the movement of Tscan Stock. The fundamental analysis module provides a way to measure Tscan Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tscan Therapeutics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Tscan Therapeutics Company Last Dividend Paid Analysis

Tscan Therapeutics' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.

Last Dividend

 = 

Last Profit Distribution Amount

Total Shares

More About Last Dividend Paid | All Equity Analysis

Tscan Last Dividend Paid Driver Correlations

Understanding the fundamental principles of building solid financial models for Tscan Therapeutics is extremely important. It helps to project a fair market value of Tscan Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Tscan Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Tscan Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Tscan Therapeutics' interrelated accounts and indicators.
0.920.890.78-0.27-0.940.740.670.930.990.980.960.720.990.71-0.67-0.45
0.920.980.77-0.43-0.920.670.451.00.940.940.870.740.920.7-0.76-0.63
0.890.980.74-0.56-0.840.640.320.960.910.920.840.730.860.58-0.62-0.51
0.780.770.74-0.41-0.760.830.480.760.810.760.720.960.780.56-0.58-0.43
-0.27-0.43-0.56-0.410.09-0.030.5-0.35-0.38-0.4-0.12-0.35-0.210.09-0.08-0.07
-0.94-0.92-0.84-0.760.09-0.8-0.74-0.94-0.91-0.9-0.94-0.74-0.95-0.730.80.61
0.740.670.640.83-0.03-0.80.70.70.680.640.840.920.720.57-0.55-0.44
0.670.450.320.480.5-0.740.70.520.580.550.740.470.710.69-0.63-0.41
0.931.00.960.76-0.35-0.940.70.520.940.940.890.730.930.73-0.78-0.65
0.990.940.910.81-0.38-0.910.680.580.941.00.910.720.980.69-0.66-0.44
0.980.940.920.76-0.4-0.90.640.550.941.00.90.680.970.68-0.64-0.43
0.960.870.840.72-0.12-0.940.840.740.890.910.90.740.930.67-0.62-0.42
0.720.740.730.96-0.35-0.740.920.470.730.720.680.740.710.54-0.55-0.47
0.990.920.860.78-0.21-0.950.720.710.930.980.970.930.710.76-0.74-0.5
0.710.70.580.560.09-0.730.570.690.730.690.680.670.540.76-0.9-0.83
-0.67-0.76-0.62-0.58-0.080.8-0.55-0.63-0.78-0.66-0.64-0.62-0.55-0.74-0.90.94
-0.45-0.63-0.51-0.43-0.070.61-0.44-0.41-0.65-0.44-0.43-0.42-0.47-0.5-0.830.94
Click cells to compare fundamentals
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition

Tscan Dividend Paid And Capex Coverage Ratio

Dividend Paid And Capex Coverage Ratio

(21.31)

At this time, Tscan Therapeutics' Dividend Paid And Capex Coverage Ratio is fairly stable compared to the past year.
Based on the recorded statements, Tscan Therapeutics has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Risk-Return Analysis Now

   

Risk-Return Analysis

View associations between returns expected from investment and the risk you assume
All  Next Launch Module

Tscan Therapeutics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Tscan Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Tscan Therapeutics' managers, analysts, and investors.
Environmental
Governance
Social

Tscan Fundamentals

About Tscan Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Tscan Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tscan Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tscan Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tscan Stock Analysis

When running Tscan Therapeutics' price analysis, check to measure Tscan Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tscan Therapeutics is operating at the current time. Most of Tscan Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tscan Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tscan Therapeutics' price. Additionally, you may evaluate how the addition of Tscan Therapeutics to your portfolios can decrease your overall portfolio volatility.